Zapping the brain to fight opioid cravings: new study tests TMS
NCT ID NCT07457489
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a non-invasive brain stimulation technique called TMS can reduce cravings and opioid use in people with opioid use disorder. One hundred participants will receive either real or sham TMS sessions over 8 weeks, with follow-up visits for about 5 months. The goal is to see if stimulating a specific brain region can help control cravings and support recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- What this could lead to
- If it works, this could point toward a non-drug treatment to help people with opioid use disorder manage cravings and reduce opioid use.
- What could go wrong
- This is an early-stage study with no direct benefit to participants. The sham control means some will get no real stimulation, and results may not lead to a proven treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOD USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Synaptic Psych
RECRUITINGBrentwood, Tennessee, 37027, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vanderbilt University Medical Center Psychiatric Hospital
RECRUITINGNashville, Tennessee, 37212, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.